(NASDAQ:SYBT), LOUISVILLE, Ky., Dec. 08, 2025 (GLOBE NEWSWIRE) — Stock Yards Bancorp, Inc. (NASDAQ: SYBT), parent company of Stock Yards Bank & Trust Company, with offices in the Louisville, central, eastern and northern Kentucky markets, as well as the Indianapolis, Indiana and Cincinnati, Ohio metropolitan markets, today announced that William J. Otten will be promoted […]

(NYSE MKT:PHGE), Following internal analysis and Data Monitoring Committee (DMC) feedback, the Company has elected to discontinue the BX004 Cystic Fibrosis (CF) Phase 2b trial BiomX continues to see potential in BX011, its phage program for Staphylococcus aureus (S. aureus) infections associated with diabetic foot infections (DFI). The Company is also implementing cost cutting measures,

Wave Life Sciences Announces Positive Interim Data from Phase 1 INLIGHT Trial of WVE-007 (INHBE) for Obesity; Single Dose Resulted in Improvement in Body Composition With Fat Loss Similar to GLP-1 at Three Months Without Muscle Loss GlobeNewswire December 08, 2025 Following a single subcutaneous 240 mg dose, WVE-007 (INHBE GalNAc-siRNA) improved body composition at

Positive Phase 1b/2 Results from Ongoing REC-4881 TUPELO Trial Demonstrate Rapid and Durable Reductions in Polyp Burden in Familial Adenomatous Polyposis (FAP) at 25 Weeks GlobeNewswire December 08, 2025 REC-4881 (4 mg QD) achieved rapid clinical activity, with 75% of evaluable patients showing reductions in total polyp burden and a 43% median reduction after 12

Onex Completes Final Realization of Ryan Specialty, Delivering Strong Investing Results GlobeNewswire December 08, 2025 All amounts in U.S. dollars unless otherwise stated TORONTO, Dec. 08, 2025 (GLOBE NEWSWIRE) — Onex Corporation (“Onex”) (TSX: ONEX) today announced that it has sold approximately 4.1 million shares of Class A Common Stock of Ryan Specialty Holdings, Inc.

Digi Power X Appoints Chief Technology Officer GlobeNewswire December 08, 2025 This news release constitutes a “designated news release” for the purposes of the Company's amended and restated prospectus supplement dated November 18, 2025, to its short form base shelf prospectus dated May 15, 2025. MIAMI, Dec. 08, 2025 (GLOBE NEWSWIRE) — Digi Power X

Cogent Biosciences Announces Positive Top-line Results of APEX Trial of Bezuclastinib in Patients with Advanced Systemic Mastocytosis (AdvSM) GlobeNewswire December 08, 2025 — Bezuclastinib demonstrated rapid and deep clinical benefit in AdvSM patients resulting in an objective response rate (CR+CRh+PR+CI) of 57% per mIWG criteria and 80% per PPR criteria — — Bezuclastinib demonstrated a

Gray Announces Private Placement of $250 Million of Additional 9.625% Senior Secured Second Lien Notes due 2032 GlobeNewswire December 08, 2025 ATLANTA, Dec. 08, 2025 (GLOBE NEWSWIRE) — Gray Media, Inc. (“Gray”) (NYSE: GTN) announced today it entered into purchase agreements (the “Purchase Agreements”) with certain accredited investors (collectively, the “Investors”), pursuant to which Gray

Dragonfly Energy Expands Marine OEM Footprint with World's Largest Power Catamaran Manufacturer, World Cat GlobeNewswire December 08, 2025 RENO, Nev., Dec. 08, 2025 (GLOBE NEWSWIRE) — Dragonfly Energy Holdings Corp. (Nasdaq: DFLI) (“Dragonfly Energy” or the “Company”), an industry leader in energy storage and maker of Battle Born Batteries(R), today announced that World Cat, the

BiomX Announces Discontinuation of Phase 2b BX004 Trial Following Internal Review GlobeNewswire December 08, 2025 Following internal analysis and Data Monitoring Committee (DMC) feedback, the Company has elected to discontinue the BX004 Cystic Fibrosis (CF) Phase 2b trial BiomX continues to see potential in BX011, its phage program for Staphylococcus aureus (S. aureus) infections associated